nodes	percent_of_prediction	percent_of_DWPC	metapath
Lubiprostone—Fibromyalgia—Citalopram—alcohol dependence	0.033	0.0513	CcSEcCtD
Lubiprostone—Frequent bowel movements—Naltrexone—alcohol dependence	0.0277	0.0431	CcSEcCtD
Lubiprostone—CLCN2—cardiovascular system—alcohol dependence	0.0266	0.105	CbGeAlD
Lubiprostone—CLCN2—gonad—alcohol dependence	0.0242	0.0955	CbGeAlD
Lubiprostone—Upset stomach—Disulfiram—alcohol dependence	0.0214	0.0332	CcSEcCtD
Lubiprostone—CLCN2—blood—alcohol dependence	0.0211	0.0832	CbGeAlD
Lubiprostone—CLCN2—endocrine gland—alcohol dependence	0.0183	0.0722	CbGeAlD
Lubiprostone—Frequent bowel movements—Citalopram—alcohol dependence	0.0175	0.0273	CcSEcCtD
Lubiprostone—CLCN2—testis—alcohol dependence	0.0174	0.0688	CbGeAlD
Lubiprostone—Functional gastrointestinal disorder—Citalopram—alcohol dependence	0.0164	0.0254	CcSEcCtD
Lubiprostone—CLCN2—cerebellum—alcohol dependence	0.0161	0.0636	CbGeAlD
Lubiprostone—CLCN2—Ion channel transport—GABRB1—alcohol dependence	0.0159	0.153	CbGpPWpGaD
Lubiprostone—CLCN2—Ion channel transport—GABRA2—alcohol dependence	0.0135	0.13	CbGpPWpGaD
Lubiprostone—CLCN2—brain—alcohol dependence	0.0131	0.0516	CbGeAlD
Lubiprostone—CBR1—forebrain—alcohol dependence	0.0126	0.0499	CbGeAlD
Lubiprostone—Loose stools—Naltrexone—alcohol dependence	0.0118	0.0183	CcSEcCtD
Lubiprostone—CBR1—adrenal cortex—alcohol dependence	0.0117	0.0462	CbGeAlD
Lubiprostone—CBR1—NRF2 pathway—ALDH3A1—alcohol dependence	0.0115	0.11	CbGpPWpGaD
Lubiprostone—CBR1—cardiovascular system—alcohol dependence	0.0107	0.0422	CbGeAlD
Lubiprostone—Upset stomach—Naltrexone—alcohol dependence	0.00996	0.0155	CcSEcCtD
Lubiprostone—Cold sweat—Citalopram—alcohol dependence	0.00972	0.0151	CcSEcCtD
Lubiprostone—CBR1—gonad—alcohol dependence	0.00969	0.0383	CbGeAlD
Lubiprostone—Pharyngolaryngeal pain—Naltrexone—alcohol dependence	0.00966	0.015	CcSEcCtD
Lubiprostone—Laryngeal pain—Naltrexone—alcohol dependence	0.00957	0.0149	CcSEcCtD
Lubiprostone—CBR1—digestive system—alcohol dependence	0.00886	0.035	CbGeAlD
Lubiprostone—CBR1—blood—alcohol dependence	0.00844	0.0334	CbGeAlD
Lubiprostone—Throat tightness—Citalopram—alcohol dependence	0.00843	0.0131	CcSEcCtD
Lubiprostone—Abdominal discomfort—Disulfiram—alcohol dependence	0.00842	0.0131	CcSEcCtD
Lubiprostone—CBR1—midbrain—alcohol dependence	0.00833	0.0329	CbGeAlD
Lubiprostone—CBR1—Arachidonic acid metabolism—GGT1—alcohol dependence	0.0079	0.0761	CbGpPWpGaD
Lubiprostone—Rectal haemorrhage—Acamprosate—alcohol dependence	0.00763	0.0119	CcSEcCtD
Lubiprostone—CBR1—NRF2 pathway—ADH7—alcohol dependence	0.0074	0.0712	CbGpPWpGaD
Lubiprostone—Chest discomfort—Naltrexone—alcohol dependence	0.00737	0.0115	CcSEcCtD
Lubiprostone—CBR1—endocrine gland—alcohol dependence	0.00732	0.0289	CbGeAlD
Lubiprostone—Gastrooesophageal reflux disease—Naltrexone—alcohol dependence	0.00722	0.0112	CcSEcCtD
Lubiprostone—CBR1—NRF2 pathway—GGT2—alcohol dependence	0.00709	0.0682	CbGpPWpGaD
Lubiprostone—CBR1—testis—alcohol dependence	0.00698	0.0276	CbGeAlD
Lubiprostone—CBR1—nervous system—alcohol dependence	0.00685	0.0271	CbGeAlD
Lubiprostone—Eructation—Acamprosate—alcohol dependence	0.00678	0.0105	CcSEcCtD
Lubiprostone—CBR1—liver—alcohol dependence	0.0066	0.0261	CbGeAlD
Lubiprostone—CBR1—central nervous system—alcohol dependence	0.0066	0.0261	CbGeAlD
Lubiprostone—CBR1—cerebellum—alcohol dependence	0.00645	0.0255	CbGeAlD
Lubiprostone—Upset stomach—Citalopram—alcohol dependence	0.00631	0.00981	CcSEcCtD
Lubiprostone—Pharyngolaryngeal pain—Citalopram—alcohol dependence	0.00612	0.00952	CcSEcCtD
Lubiprostone—Laryngeal pain—Citalopram—alcohol dependence	0.00606	0.00943	CcSEcCtD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.00553	0.0532	CbGpPWpGaD
Lubiprostone—Swelling—Naltrexone—alcohol dependence	0.00537	0.00835	CcSEcCtD
Lubiprostone—CBR1—brain—alcohol dependence	0.00524	0.0207	CbGeAlD
Lubiprostone—Lethargy—Naltrexone—alcohol dependence	0.00483	0.00752	CcSEcCtD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.0047	0.0453	CbGpPWpGaD
Lubiprostone—Chest discomfort—Citalopram—alcohol dependence	0.00467	0.00727	CcSEcCtD
Lubiprostone—Rectal haemorrhage—Citalopram—alcohol dependence	0.00458	0.00712	CcSEcCtD
Lubiprostone—Gastrooesophageal reflux disease—Citalopram—alcohol dependence	0.00458	0.00712	CcSEcCtD
Lubiprostone—Aspartate aminotransferase increased—Acamprosate—alcohol dependence	0.00451	0.00701	CcSEcCtD
Lubiprostone—Gastritis—Acamprosate—alcohol dependence	0.00443	0.00689	CcSEcCtD
Lubiprostone—Alanine aminotransferase increased—Acamprosate—alcohol dependence	0.00441	0.00687	CcSEcCtD
Lubiprostone—Abdominal distension—Acamprosate—alcohol dependence	0.00436	0.00677	CcSEcCtD
Lubiprostone—Influenza—Acamprosate—alcohol dependence	0.00433	0.00673	CcSEcCtD
Lubiprostone—Fatigue—Disulfiram—alcohol dependence	0.00431	0.0067	CcSEcCtD
Lubiprostone—Pain—Disulfiram—alcohol dependence	0.00427	0.00664	CcSEcCtD
Lubiprostone—Cramp muscle—Naltrexone—alcohol dependence	0.00426	0.00663	CcSEcCtD
Lubiprostone—Aspartate aminotransferase increased—Naltrexone—alcohol dependence	0.00426	0.00663	CcSEcCtD
Lubiprostone—Alanine aminotransferase increased—Naltrexone—alcohol dependence	0.00418	0.0065	CcSEcCtD
Lubiprostone—Influenza—Naltrexone—alcohol dependence	0.00409	0.00637	CcSEcCtD
Lubiprostone—Eructation—Citalopram—alcohol dependence	0.00406	0.00632	CcSEcCtD
Lubiprostone—Pollakiuria—Acamprosate—alcohol dependence	0.004	0.00621	CcSEcCtD
Lubiprostone—CBR1—NRF2 pathway—SLC6A4—alcohol dependence	0.00399	0.0384	CbGpPWpGaD
Lubiprostone—Weight increased—Acamprosate—alcohol dependence	0.00394	0.00612	CcSEcCtD
Lubiprostone—Abdominal discomfort—Naltrexone—alcohol dependence	0.00392	0.0061	CcSEcCtD
Lubiprostone—Urinary tract infection—Acamprosate—alcohol dependence	0.00375	0.00583	CcSEcCtD
Lubiprostone—Weight increased—Naltrexone—alcohol dependence	0.00373	0.00579	CcSEcCtD
Lubiprostone—Asthenia—Disulfiram—alcohol dependence	0.00358	0.00557	CcSEcCtD
Lubiprostone—CBR1—NRF2 pathway—SLC6A3—alcohol dependence	0.00356	0.0343	CbGpPWpGaD
Lubiprostone—Urinary tract infection—Naltrexone—alcohol dependence	0.00355	0.00552	CcSEcCtD
Lubiprostone—Oedema peripheral—Acamprosate—alcohol dependence	0.00341	0.0053	CcSEcCtD
Lubiprostone—CBR1—NRF2 pathway—GGT1—alcohol dependence	0.00335	0.0323	CbGpPWpGaD
Lubiprostone—Dizziness—Disulfiram—alcohol dependence	0.0033	0.00514	CcSEcCtD
Lubiprostone—Connective tissue disorder—Naltrexone—alcohol dependence	0.00322	0.00501	CcSEcCtD
Lubiprostone—Rash—Disulfiram—alcohol dependence	0.00315	0.0049	CcSEcCtD
Lubiprostone—Headache—Disulfiram—alcohol dependence	0.00313	0.00487	CcSEcCtD
Lubiprostone—Lethargy—Citalopram—alcohol dependence	0.00306	0.00476	CcSEcCtD
Lubiprostone—Mental disorder—Acamprosate—alcohol dependence	0.00303	0.00472	CcSEcCtD
Lubiprostone—Malnutrition—Acamprosate—alcohol dependence	0.00301	0.00469	CcSEcCtD
Lubiprostone—Flatulence—Acamprosate—alcohol dependence	0.00297	0.00462	CcSEcCtD
Lubiprostone—Mediastinal disorder—Naltrexone—alcohol dependence	0.00295	0.00459	CcSEcCtD
Lubiprostone—Dysgeusia—Acamprosate—alcohol dependence	0.00295	0.00459	CcSEcCtD
Lubiprostone—Muscle spasms—Acamprosate—alcohol dependence	0.0029	0.00451	CcSEcCtD
Lubiprostone—Mental disorder—Naltrexone—alcohol dependence	0.00287	0.00446	CcSEcCtD
Lubiprostone—Malnutrition—Naltrexone—alcohol dependence	0.00285	0.00444	CcSEcCtD
Lubiprostone—Tremor—Acamprosate—alcohol dependence	0.00282	0.00439	CcSEcCtD
Lubiprostone—Flatulence—Naltrexone—alcohol dependence	0.00281	0.00437	CcSEcCtD
Lubiprostone—Ill-defined disorder—Acamprosate—alcohol dependence	0.0028	0.00435	CcSEcCtD
Lubiprostone—Dysgeusia—Naltrexone—alcohol dependence	0.00279	0.00434	CcSEcCtD
Lubiprostone—Muscle spasms—Naltrexone—alcohol dependence	0.00274	0.00426	CcSEcCtD
Lubiprostone—Malaise—Acamprosate—alcohol dependence	0.00272	0.00423	CcSEcCtD
Lubiprostone—Syncope—Acamprosate—alcohol dependence	0.0027	0.0042	CcSEcCtD
Lubiprostone—Cramp muscle—Citalopram—alcohol dependence	0.0027	0.0042	CcSEcCtD
Lubiprostone—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.0027	0.0042	CcSEcCtD
Lubiprostone—Tremor—Naltrexone—alcohol dependence	0.00267	0.00416	CcSEcCtD
Lubiprostone—Palpitations—Acamprosate—alcohol dependence	0.00266	0.00414	CcSEcCtD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	0.00266	0.0256	CbGpPWpGaD
Lubiprostone—Gastritis—Citalopram—alcohol dependence	0.00266	0.00413	CcSEcCtD
Lubiprostone—Loss of consciousness—Acamprosate—alcohol dependence	0.00265	0.00412	CcSEcCtD
Lubiprostone—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.00265	0.00412	CcSEcCtD
Lubiprostone—Ill-defined disorder—Naltrexone—alcohol dependence	0.00265	0.00412	CcSEcCtD
Lubiprostone—Cough—Acamprosate—alcohol dependence	0.00263	0.00409	CcSEcCtD
Lubiprostone—Abdominal distension—Citalopram—alcohol dependence	0.00261	0.00406	CcSEcCtD
Lubiprostone—Influenza—Citalopram—alcohol dependence	0.00259	0.00403	CcSEcCtD
Lubiprostone—Malaise—Naltrexone—alcohol dependence	0.00257	0.004	CcSEcCtD
Lubiprostone—Myalgia—Acamprosate—alcohol dependence	0.00257	0.00399	CcSEcCtD
Lubiprostone—Chest pain—Acamprosate—alcohol dependence	0.00257	0.00399	CcSEcCtD
Lubiprostone—Syncope—Naltrexone—alcohol dependence	0.00256	0.00398	CcSEcCtD
Lubiprostone—Anxiety—Acamprosate—alcohol dependence	0.00256	0.00398	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.00255	0.00396	CcSEcCtD
Lubiprostone—Discomfort—Acamprosate—alcohol dependence	0.00254	0.00394	CcSEcCtD
Lubiprostone—Palpitations—Naltrexone—alcohol dependence	0.00252	0.00392	CcSEcCtD
Lubiprostone—Dry mouth—Acamprosate—alcohol dependence	0.00251	0.0039	CcSEcCtD
Lubiprostone—Loss of consciousness—Naltrexone—alcohol dependence	0.00251	0.0039	CcSEcCtD
Lubiprostone—Cough—Naltrexone—alcohol dependence	0.00249	0.00387	CcSEcCtD
Lubiprostone—Abdominal discomfort—Citalopram—alcohol dependence	0.00249	0.00387	CcSEcCtD
Lubiprostone—Chest pain—Naltrexone—alcohol dependence	0.00243	0.00378	CcSEcCtD
Lubiprostone—Myalgia—Naltrexone—alcohol dependence	0.00243	0.00378	CcSEcCtD
Lubiprostone—Shock—Acamprosate—alcohol dependence	0.00242	0.00376	CcSEcCtD
Lubiprostone—Anxiety—Naltrexone—alcohol dependence	0.00242	0.00376	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.00241	0.00375	CcSEcCtD
Lubiprostone—Tachycardia—Acamprosate—alcohol dependence	0.0024	0.00373	CcSEcCtD
Lubiprostone—Discomfort—Naltrexone—alcohol dependence	0.0024	0.00373	CcSEcCtD
Lubiprostone—Pollakiuria—Citalopram—alcohol dependence	0.0024	0.00373	CcSEcCtD
Lubiprostone—Skin disorder—Acamprosate—alcohol dependence	0.00239	0.00372	CcSEcCtD
Lubiprostone—Hyperhidrosis—Acamprosate—alcohol dependence	0.00238	0.0037	CcSEcCtD
Lubiprostone—Dry mouth—Naltrexone—alcohol dependence	0.00237	0.00369	CcSEcCtD
Lubiprostone—Weight increased—Citalopram—alcohol dependence	0.00236	0.00367	CcSEcCtD
Lubiprostone—Anorexia—Acamprosate—alcohol dependence	0.00235	0.00365	CcSEcCtD
Lubiprostone—Oedema—Naltrexone—alcohol dependence	0.00233	0.00362	CcSEcCtD
Lubiprostone—Shock—Naltrexone—alcohol dependence	0.00229	0.00356	CcSEcCtD
Lubiprostone—Nervous system disorder—Naltrexone—alcohol dependence	0.00228	0.00355	CcSEcCtD
Lubiprostone—Tachycardia—Naltrexone—alcohol dependence	0.00227	0.00353	CcSEcCtD
Lubiprostone—Skin disorder—Naltrexone—alcohol dependence	0.00226	0.00352	CcSEcCtD
Lubiprostone—Hyperhidrosis—Naltrexone—alcohol dependence	0.00225	0.0035	CcSEcCtD
Lubiprostone—Urinary tract infection—Citalopram—alcohol dependence	0.00225	0.0035	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.00224	0.00349	CcSEcCtD
Lubiprostone—Anorexia—Naltrexone—alcohol dependence	0.00222	0.00345	CcSEcCtD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—AVP—alcohol dependence	0.0022	0.0212	CbGpPWpGaD
Lubiprostone—Dyspnoea—Acamprosate—alcohol dependence	0.00219	0.00341	CcSEcCtD
Lubiprostone—Dyspepsia—Acamprosate—alcohol dependence	0.00217	0.00337	CcSEcCtD
Lubiprostone—Decreased appetite—Acamprosate—alcohol dependence	0.00214	0.00333	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.00212	0.0033	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.00212	0.0033	CcSEcCtD
Lubiprostone—Pain—Acamprosate—alcohol dependence	0.0021	0.00327	CcSEcCtD
Lubiprostone—Constipation—Acamprosate—alcohol dependence	0.0021	0.00327	CcSEcCtD
Lubiprostone—Dyspnoea—Naltrexone—alcohol dependence	0.00208	0.00323	CcSEcCtD
Lubiprostone—Oedema peripheral—Citalopram—alcohol dependence	0.00205	0.00318	CcSEcCtD
Lubiprostone—Connective tissue disorder—Citalopram—alcohol dependence	0.00204	0.00317	CcSEcCtD
Lubiprostone—Feeling abnormal—Acamprosate—alcohol dependence	0.00203	0.00315	CcSEcCtD
Lubiprostone—Decreased appetite—Naltrexone—alcohol dependence	0.00202	0.00315	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Acamprosate—alcohol dependence	0.00201	0.00313	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.00201	0.00312	CcSEcCtD
Lubiprostone—Fatigue—Naltrexone—alcohol dependence	0.00201	0.00312	CcSEcCtD
Lubiprostone—Constipation—Naltrexone—alcohol dependence	0.00199	0.0031	CcSEcCtD
Lubiprostone—Pain—Naltrexone—alcohol dependence	0.00199	0.0031	CcSEcCtD
Lubiprostone—Abdominal pain—Acamprosate—alcohol dependence	0.00194	0.00302	CcSEcCtD
Lubiprostone—Feeling abnormal—Naltrexone—alcohol dependence	0.00192	0.00298	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Naltrexone—alcohol dependence	0.0019	0.00296	CcSEcCtD
Lubiprostone—Mediastinal disorder—Citalopram—alcohol dependence	0.00187	0.00291	CcSEcCtD
Lubiprostone—CBR1—Metabolism—ADH6—alcohol dependence	0.00185	0.0178	CbGpPWpGaD
Lubiprostone—Abdominal pain—Naltrexone—alcohol dependence	0.00184	0.00286	CcSEcCtD
Lubiprostone—Mental disorder—Citalopram—alcohol dependence	0.00182	0.00283	CcSEcCtD
Lubiprostone—Hypersensitivity—Acamprosate—alcohol dependence	0.00181	0.00282	CcSEcCtD
Lubiprostone—Erythema—Citalopram—alcohol dependence	0.00181	0.00281	CcSEcCtD
Lubiprostone—Malnutrition—Citalopram—alcohol dependence	0.00181	0.00281	CcSEcCtD
Lubiprostone—Flatulence—Citalopram—alcohol dependence	0.00178	0.00277	CcSEcCtD
Lubiprostone—Dysgeusia—Citalopram—alcohol dependence	0.00177	0.00275	CcSEcCtD
Lubiprostone—Asthenia—Acamprosate—alcohol dependence	0.00177	0.00274	CcSEcCtD
Lubiprostone—Muscle spasms—Citalopram—alcohol dependence	0.00174	0.0027	CcSEcCtD
Lubiprostone—Hypersensitivity—Naltrexone—alcohol dependence	0.00171	0.00267	CcSEcCtD
Lubiprostone—Tremor—Citalopram—alcohol dependence	0.00169	0.00263	CcSEcCtD
Lubiprostone—Diarrhoea—Acamprosate—alcohol dependence	0.00168	0.00262	CcSEcCtD
Lubiprostone—Ill-defined disorder—Citalopram—alcohol dependence	0.00168	0.00261	CcSEcCtD
Lubiprostone—Asthenia—Naltrexone—alcohol dependence	0.00167	0.0026	CcSEcCtD
Lubiprostone—Malaise—Citalopram—alcohol dependence	0.00163	0.00253	CcSEcCtD
Lubiprostone—Dizziness—Acamprosate—alcohol dependence	0.00163	0.00253	CcSEcCtD
Lubiprostone—Syncope—Citalopram—alcohol dependence	0.00162	0.00252	CcSEcCtD
Lubiprostone—Palpitations—Citalopram—alcohol dependence	0.0016	0.00248	CcSEcCtD
Lubiprostone—Diarrhoea—Naltrexone—alcohol dependence	0.00159	0.00248	CcSEcCtD
Lubiprostone—Loss of consciousness—Citalopram—alcohol dependence	0.00159	0.00247	CcSEcCtD
Lubiprostone—Cough—Citalopram—alcohol dependence	0.00158	0.00245	CcSEcCtD
Lubiprostone—Vomiting—Acamprosate—alcohol dependence	0.00156	0.00243	CcSEcCtD
Lubiprostone—Rash—Acamprosate—alcohol dependence	0.00155	0.00241	CcSEcCtD
Lubiprostone—Dermatitis—Acamprosate—alcohol dependence	0.00155	0.00241	CcSEcCtD
Lubiprostone—Headache—Acamprosate—alcohol dependence	0.00154	0.0024	CcSEcCtD
Lubiprostone—Dizziness—Naltrexone—alcohol dependence	0.00154	0.00239	CcSEcCtD
Lubiprostone—Myalgia—Citalopram—alcohol dependence	0.00154	0.00239	CcSEcCtD
Lubiprostone—Chest pain—Citalopram—alcohol dependence	0.00154	0.00239	CcSEcCtD
Lubiprostone—CBR1—Metabolism—ADH1A—alcohol dependence	0.00153	0.0148	CbGpPWpGaD
Lubiprostone—Anxiety—Citalopram—alcohol dependence	0.00153	0.00238	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.00153	0.00238	CcSEcCtD
Lubiprostone—Discomfort—Citalopram—alcohol dependence	0.00152	0.00236	CcSEcCtD
Lubiprostone—Dry mouth—Citalopram—alcohol dependence	0.0015	0.00234	CcSEcCtD
Lubiprostone—Vomiting—Naltrexone—alcohol dependence	0.00148	0.0023	CcSEcCtD
Lubiprostone—Oedema—Citalopram—alcohol dependence	0.00147	0.00229	CcSEcCtD
Lubiprostone—Rash—Naltrexone—alcohol dependence	0.00147	0.00228	CcSEcCtD
Lubiprostone—Dermatitis—Naltrexone—alcohol dependence	0.00147	0.00228	CcSEcCtD
Lubiprostone—Nausea—Acamprosate—alcohol dependence	0.00146	0.00227	CcSEcCtD
Lubiprostone—Headache—Naltrexone—alcohol dependence	0.00146	0.00227	CcSEcCtD
Lubiprostone—Shock—Citalopram—alcohol dependence	0.00145	0.00226	CcSEcCtD
Lubiprostone—Nervous system disorder—Citalopram—alcohol dependence	0.00145	0.00225	CcSEcCtD
Lubiprostone—Tachycardia—Citalopram—alcohol dependence	0.00144	0.00224	CcSEcCtD
Lubiprostone—Skin disorder—Citalopram—alcohol dependence	0.00143	0.00223	CcSEcCtD
Lubiprostone—Hyperhidrosis—Citalopram—alcohol dependence	0.00143	0.00222	CcSEcCtD
Lubiprostone—Anorexia—Citalopram—alcohol dependence	0.00141	0.00219	CcSEcCtD
Lubiprostone—Nausea—Naltrexone—alcohol dependence	0.00138	0.00215	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.00134	0.00209	CcSEcCtD
Lubiprostone—Dyspnoea—Citalopram—alcohol dependence	0.00131	0.00204	CcSEcCtD
Lubiprostone—CBR1—Metabolism—ADH4—alcohol dependence	0.0013	0.0126	CbGpPWpGaD
Lubiprostone—Dyspepsia—Citalopram—alcohol dependence	0.0013	0.00202	CcSEcCtD
Lubiprostone—Decreased appetite—Citalopram—alcohol dependence	0.00128	0.00199	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Citalopram—alcohol dependence	0.00127	0.00198	CcSEcCtD
Lubiprostone—Fatigue—Citalopram—alcohol dependence	0.00127	0.00198	CcSEcCtD
Lubiprostone—Pain—Citalopram—alcohol dependence	0.00126	0.00196	CcSEcCtD
Lubiprostone—Constipation—Citalopram—alcohol dependence	0.00126	0.00196	CcSEcCtD
Lubiprostone—Feeling abnormal—Citalopram—alcohol dependence	0.00122	0.00189	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Citalopram—alcohol dependence	0.00121	0.00188	CcSEcCtD
Lubiprostone—Abdominal pain—Citalopram—alcohol dependence	0.00117	0.00181	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	0.00113	0.0109	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ADH7—alcohol dependence	0.00111	0.0107	CbGpPWpGaD
Lubiprostone—Hypersensitivity—Citalopram—alcohol dependence	0.00109	0.00169	CcSEcCtD
Lubiprostone—CBR1—Metabolism—GGT2—alcohol dependence	0.00106	0.0102	CbGpPWpGaD
Lubiprostone—Asthenia—Citalopram—alcohol dependence	0.00106	0.00165	CcSEcCtD
Lubiprostone—Diarrhoea—Citalopram—alcohol dependence	0.00101	0.00157	CcSEcCtD
Lubiprostone—Dizziness—Citalopram—alcohol dependence	0.000975	0.00152	CcSEcCtD
Lubiprostone—CBR1—Metabolism—ADH1B—alcohol dependence	0.000973	0.00936	CbGpPWpGaD
Lubiprostone—Vomiting—Citalopram—alcohol dependence	0.000938	0.00146	CcSEcCtD
Lubiprostone—Rash—Citalopram—alcohol dependence	0.00093	0.00145	CcSEcCtD
Lubiprostone—Dermatitis—Citalopram—alcohol dependence	0.000929	0.00144	CcSEcCtD
Lubiprostone—Headache—Citalopram—alcohol dependence	0.000924	0.00144	CcSEcCtD
Lubiprostone—Nausea—Citalopram—alcohol dependence	0.000876	0.00136	CcSEcCtD
Lubiprostone—CBR1—Metabolism—MAOB—alcohol dependence	0.000806	0.00776	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ALDH2—alcohol dependence	0.000685	0.0066	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	0.000659	0.00634	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GOT2—alcohol dependence	0.000583	0.00561	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CYP2E1—alcohol dependence	0.000548	0.00527	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GOT1—alcohol dependence	0.000503	0.00484	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GGT1—alcohol dependence	0.000503	0.00484	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—MAOA—alcohol dependence	0.000451	0.00434	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	0.000437	0.00421	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—POMC—alcohol dependence	0.000293	0.00282	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—EP300—alcohol dependence	0.000195	0.00187	CbGpPWpGaD
